Health Technology
Belgian companies developing health technologies
Developing medical devices, diagnostics, and healthcare software platforms defines the health technology sector. Regulatory approval timelines and shifting Medicare reimbursement models constantly inject liquidity into these equities. Currently, Oxurion NV dominates trading volume, whereas UCB S.A. logs the strongest 24-hour performance. The table below organizes vital technical and fundamental data points.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|
 UCBUCB S.A. | 53.69 B EUR | 290.9 EUR | +0.24% | 260.81 K | 0.83 | 25.73 | 11.31 EUR | +64.98% | 0.36% | Buy |
 ARGXargenx SE | 51.25 B EUR | 815.8 EUR | +0.02% | 102.85 K | 1.14 | 36.24 | 22.51 EUR | +24.40% | 0.00% | Strong buy |
 IBABIon Beam Applications SA | 491.26 M EUR | 16.36 EUR | −1.56% | 10.67 K | 0.77 | 20.07 | 0.82 EUR | +40.53% | 1.06% | Buy |
 ONWDOnward Medical N.V. | 132.1 M EUR | 1.780 EUR | −0.89% | 204.94 K | 0.65 | — | — | — | 0.00% | Strong buy |
 HYLHyloris Pharmaceuticals SA | 102.76 M EUR | 3.49 EUR | −0.29% | 1.99 K | 0.33 | — | −0.17 EUR | +27.42% | 0.00% | Buy |
 NYXHNyxoah SA | 79.84 M EUR | 0.754 EUR | −1.57% | 229.21 K | 1.02 | — | −2.16 EUR | −2.59% | 0.00% | Buy |
 ALEMSEuropean Medical Solutions. | 14.81 M EUR | 3.40 EUR | −2.86% | 24 | 0.94 | 7.44 | 0.46 EUR | +64.94% | 0.00% | No rating |
 CYADCelyad Oncology SA | 8.65 M EUR | 0.1780 EUR | −1.11% | 18.43 K | 1.69 | 2.18 | 0.08 EUR | — | 0.00% | No rating |
 OXUROxurion NV | 185.6 K EUR | 0.0008 EUR | 0.00% | 1.26 M | 0.31 | — | −0.05 EUR | −102.09% | 0.00% | No rating |